Skip to main content

Table 6 Mean Ht value and TLC estimated throughout the observation period in both groups

From: Sequential E2 levels not ovarian maximal diameter estimates were correlated with outcome of cetrotide therapy for management of women at high-risk of ovarian hyperstimulation syndrome: a randomized controlled study

 

Ht value (%)

TLC (103/ml)

 

Control

Study

Control

Study

Day-0

39.8 ± 4.2

42.2 ± 5.2

11.6 ± 3.7

12.75 ± 3.1

Day-3

38.8 ± 3.3

38.7 ± 3.3a

11.3 ± 3.6

11.5 ± 2.8a

Day-6

38 ± 3.1

37.3 ± 2.5a

11.2 ± 3.6

11 ± 1.9a

Day-8

37.5 ± 1.5a

36.8 ± 2.6a

10.1 ± 2.2a

9.75 ± 3.1a

  1. Data are presented as mean (±SD); a: significant difference versus respective Day-0 data